StonvexLoading…
StonvexStonvexStonvexCore line items from THRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.50B | $1.46B | $1.47B | $1.20B |
Operating Income | $82.70M | $107.02M | $77.44M | $48.31M |
Net Income | $18.29M | $64.95M | $40.34M | $24.44M |
EPS (Diluted) | $0.59 | $2.06 | $1.22 | $0.73 |
Total Assets | $1.40B | $1.25B | $1.23B | $1.24B |
Total Liabilities | $676.11M | $630.61M | $589.65M | $567.03M |
Cash & Equivalents | $160.83M | $134.13M | $149.67M | $153.89M |
Free Cash Flow OCF − CapEx | $61.12M | $36.33M | $81.66M | $-24.76M |
Shares Outstanding | 30.53M | 30.79M | 31.54M | 33.20M |